|Day Low/High||19.00 / 19.89|
|52 Wk Low/High||12.90 / 28.35|
TheStreet's Jim Cramer agrees with analysts on Netflix and says Celladon is an example of 'biotech FDA roulette.'
Stocks are moving higher on Monday, adding to record highs for the S&P 500 and Nasdaq achieved on Friday.
Will the failure of Celladon's Mydicar gene therapy bring other high-flying gene therapy stocks down to Earth?
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
Investor Call Scheduled for 8:30am Eastern on Tuesday, March 31, 2015
In April, Celladon is expecting results from a mid-stage study of a gene therapy aiming to improve the pumping ability of the heart in patients with advanced heart failure.
Cramer likes Celladon and Sirius XM Radio, thinks Centene is amazing and is avoiding King Digital and Virgin America.
Cramer says it's time to take some profits and raise cash for the next speed bump. He'll be watching company earnings from Sonic, Paychex and GameStop, among others.
Rite Aid Corporation (NYSE:RAD), USA Truck Inc. (NASDAQ:USAK) and Celladon Corp. (NASDAQ:CLDN) made big morning gains this Wednesday. AOL Inc. (NYSE:AOL), Seventy Seven Energy Inc. (NYSE:SSE) and Inte...
Getting in on a hot IPO may prove difficult for most retail investors. That doesn't mean there aren't gains to be made. Here are the best performing IPOs in 2014.
Today's gold rally resulted in climbs for Kinross Gold Corporation (NYSE:KGC), Yamana Gold Inc. (NYSE:AUY) and AuRico Gold Inc. (NYSE:AUQ). CHC Grop Ltd. (NYSE:HELI), Celladon Corp. (NASDAQ:CLDN) an...
2,000L Demonstration Batch Completed at Lonza, Houston Facility
Sears Hometown and Outlet Stores Inc (NASDAQ:SHOS), Celladon Corp (NASDAQ:CLDN) and Repros Therapeutics Inc (NASDAQ:RPRX) are gaining this Monday. Gulf Coast Ultra Deep Royalty Trust (NASDAQ:GULTU),¿...
Now Presenting November 12 at 11:30 am MST
New Gene Therapy Approach Shown to Reverse Heart Damage and Improve Long Term Cardiac Function Following Myocardial Infarction in Animal Models
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.